The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

Mitchell S. Stark; Kerenaftali Klein; Benjamin Weide; Lauren E. Haydu; Annette Pflugfelder; Yue Hang Tang; Jane M. Palmer; David C. Whiteman; Richard A. Scolyer; Graham J. Mann; John F. Thompson; Georgina V. Long; Andrew P. Barbour; H. Peter Soyer; Claus Garbe; Adrian Herington; Pamela M. Pollock; Nicholas K. Hayward

Journal ArticleOPEN ACCESS

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

Stark M
Klein K
Weide B
et al.

EBioMedicine (2015) 2(7) 671-680

DOI: 10.1016/j.ebiom.2015.05.011

83Citations

93Readers

Abstract

The overall 5-year survival for melanoma is 91%. However, if distant metastasis occurs (stage IV), cure rates are

Author supplied keywords

Biomarker
Diagnostic
Melanoma
MiRNA
MicroRNA
Prognostic

Cite

CITATION STYLE

APA

Stark, M. S., Klein, K., Weide, B., Haydu, L. E., Pflugfelder, A., Tang, Y. H., … Hayward, N. K. (2015). The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis. EBioMedicine, 2(7), 671–680. https://doi.org/10.1016/j.ebiom.2015.05.011

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis

Abstract

Author supplied keywords

Cite

Register to see more suggestions